key: cord-0950780-jjz542cp authors: Kamath, Yogish Subraya; George, Neenu Mariam; Sarpangala, Shailaja; Kulkarni, Chidanand title: Response to comment on: Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic - A case report date: 2022-01-03 journal: Indian J Ophthalmol DOI: 10.4103/ijo.ijo_2560_21 sha: d20889326ee5cb07e6fb1d05f64e83e302b4e16e doc_id: 950780 cord_uid: jjz542cp nan This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Dear Editor, We thank the author for the valuable inputs regarding our case report, [1] and for giving us an opportunity to discuss a few additional aspects, which we were unable to do due to space limitations in the original report. [2] As described in our report, our case, a young healthy male, who presented with a sudden unilateral decrease in vision, was referred to us with a diagnosis of central retinal venous occlusion (CRVO). Although initially suspected and evaluated for CRVO in the young, including serum homocysteine, the presence of inflammatory features, including the anterior chamber cells and retinal vasculitis, led us to consider toxoplasmosis and sarcoidosis as differentials. The optical coherence tomography features confirming the suspected area of perivascular retinitis along the superior temporal arcade and the increased possibility of Herpes virus retinitis during the COVID-19 pandemic led us to investigate further, revealing polymerase chain reaction (PCR) positivity of aqueous humor for varicella zoster virus (VZV). [3] This also helped us exclude toxoplasmosis, which would have had a different line of treatment. The treatment with oral valaciclovir was initiated on the fifth day after the onset of symptoms. The steroids were initiated after three days of starting the antiviral therapy. We agree with the author that the retinitis patch around the superior temporal arcade appeared more prominent and larger than at presentation. This was, however, associated with a generalized decrease in vessel caliber and sheathing in other areas. There was also a decrease in retinal edema in the peripapillary region. Thus, we felt there was an overall clinical resolution. The vitreous haze and visual acuity did not worsen after the initiation of antiviral therapy. In view of the negative Mantoux test and a positive serum angiotensin-converting enzyme, sarcoidosis was considered as a differential. A systemic evaluation by the physician was performed, including a chest X-ray, which was normal. In presence of the highly specific test of PCR for VZV from the aqueous humor being positive, additional tests for sarcoidosis, such as high-resolution computed tomography, were not performed due to financial constraints. The patient is currently under regular follow-up with his physician for both monitoring of sarcoidosis and cardiovascular screening due to elevated serum homocysteine levels. Dietary modifications and vitamin B6, B12, and folic acid supplementation have also been advised. [4] Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic-A case report Ocular sarcoidosis: New diagnostic modalities and treatment Plasma homocysteine in patients with retinal vein occlusion Comment on: Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic -A case report Aqueous humor polymerase chain reaction in uveitis-utility and safety The treatment of hyperhomocysteinemia Bilateral paracentral acute middle maculopathy and acute macular neuroretinopathy following COVID-19 vaccination Optical coherence tomography angiography: Potential artifacts in acute macular neuroretinopathy Retinal microvasculature alteration in paracentral acute middle maculopathy and acute macular neuroretinopathy: A quantitative optical coherence tomography angiography study Dear Editor, We read with interest the article by Vinzamuri et al. [1] The hyperreflective lesions seen on ganglion layer could represent sections across the vessels. It would be helpful if the optical coherence tomography images would be accompanied by section through which it was taken. Since acute macular neuroretinopathy (AMN) and paracentral middle maculopathy (PAMM) are possibly related to vascular occlusion either a fundus fluorescein angiography or optical coherence tomography angiography can add value to their case. In AMN, changes occur due to reduced retinal perfusion at the level of deep capillary plexus, which provides retinal perfusion to the zone between the retinal and choroidal circulations. [2, 3] AMN multimodal imaging findings described could be dark lesions on red-free imaging, hypo-autofluorescence on fundus autofluorescence, and early and late hypofluorescence on fluorescein angiography. Infrared imaging also detected the lesions with a darkened outline. [4] Despite complete visual recovery, there is a possibility of persisting scotoma which may be as a result of thinning of the affected retinal layers. [5] We agree with the authors that AMN and PAMM following COVID-19 vaccine may not be causal and may have to be explored further. Nil.